The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-28
DOI
10.3389/fendo.2020.00474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia
- (2020) Tianhua Zhang et al. CLINICAL BIOCHEMISTRY
- Nucleic Acid–Based Therapies for Atherosclerosis
- (2020) Petri Mäkinen et al. Current Atherosclerosis Reports
- ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis
- (2020) Romain Capoulade et al. HEART
- Dual apoC-II mimetic and apoC-III antagonist for hypertriglyceridaemia
- (2020) Karina Huynh Nature Reviews Cardiology
- A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
- (2020) Anna Wolska et al. Science Translational Medicine
- Apolipoprotein C-II
- (2020) Anna Wolska et al. CURRENT OPINION IN LIPIDOLOGY
- The next generation of triglyceride-lowering drugs
- (2020) Laurens F. Reeskamp et al. CURRENT OPINION IN LIPIDOLOGY
- Apolipoprotein C-III Strongly Correlates with Activated Factor VII–Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation
- (2019) Marcello Baroni et al. THROMBOSIS AND HAEMOSTASIS
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia
- (2019) Martin Adiels et al. DIABETES OBESITY & METABOLISM
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- ApoC-III ASO Promotes Tissue LPL Activity in Absence of ApoE-Mediated TRL Clearance
- (2019) Bastian Ramms et al. JOURNAL OF LIPID RESEARCH
- Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
- (2019) Bettina Hieronimus et al. Journal of Clinical Medicine
- Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
- (2019) Jenny E. Kanter et al. JOURNAL OF CLINICAL INVESTIGATION
- Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?
- (2019) Henry N. Ginsberg et al. JOURNAL OF CLINICAL INVESTIGATION
- ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors
- (2019) Natalie C. Kegulian et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dietary Fructose and the Metabolic Syndrome
- (2019) Taskinen et al. Nutrients
- Dietary fructose and dyslipidemia
- (2019) Bettina Hieronimus et al. CURRENT OPINION IN LIPIDOLOGY
- Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII
- (2019) Oliviero Olivieri et al. STROKE
- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans
- (2018) Adil Mardinoglu et al. Cell Metabolism
- Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
- (2018) Bastian Ramms et al. CURRENT OPINION IN LIPIDOLOGY
- Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths
- (2018) Maija Ruuth et al. EUROPEAN HEART JOURNAL
- Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS †
- (2018) Andres Gelrud et al. Journal of Clinical Lipidology
- Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials
- (2018) Amirhossein Sahebkar et al. Journal of Clinical Lipidology
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Broad Views of Non-alcoholic Fatty Liver Disease
- (2018) Adil Mardinoglu et al. Cell Systems
- Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial
- (2018) Jeremy D Furtado et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials
- (2018) Amirhossein Sahebkar et al. ANNALS OF MEDICINE
- Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
- (2018) Gissette Reyes-Soffer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program
- (2018) Derek Klarin et al. NATURE GENETICS
- Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity
- (2017) Jean-Marc Schwarz et al. GASTROENTEROLOGY
- Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions
- (2017) Saulo Mendoza et al. Journal of Clinical Lipidology
- Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
- (2017) M.-R. Taskinen et al. JOURNAL OF INTERNAL MEDICINE
- Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine
- (2017) Javeed Jattan et al. JOURNAL OF LIPID RESEARCH
- The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation
- (2017) Meenakshi Sundaram et al. JOURNAL OF LIPID RESEARCH
- Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition
- (2017) Nathan L. Meyers et al. JOURNAL OF LIPID RESEARCH
- Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
- (2017) Jan Oscarsson et al. Lipids in Health and Disease
- Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity
- (2017) Danish Saleheen et al. NATURE
- Exome-wide association study of plasma lipids in >300,000 individuals
- (2017) Dajiang J Liu et al. NATURE GENETICS
- Increasing Lipolysis and Reducing Atherosclerosis
- (2017) Alan R. Tall NEW ENGLAND JOURNAL OF MEDICINE
- Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
- (2016) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of omega-3 carboxylic acids on apolipoprotein CIII−containing lipoproteins in severe hypertriglyceridemia
- (2016) Allyson M. Morton et al. Journal of Clinical Lipidology
- Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
- (2016) Juraj Koska et al. JOURNAL OF LIPID RESEARCH
- A dose-response study of consuming high-fructose corn syrup–sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults
- (2015) Kimber L Stanhope et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal ObesitySignificance
- (2015) Jan Borén et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
- (2015) Moritz C. Wyler von Ballmoos et al. Journal of Clinical Lipidology
- Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial
- (2015) Richard L. Dunbar et al. Lipids in Health and Disease
- Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms
- (2015) Olgica Trenchevska et al. METHODS
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
- (2015) Karin Åvall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Apolipoprotein C-III: From Pathophysiology to Pharmacology
- (2015) Giuseppe Danilo Norata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Apolipoprotein C-III
- (2015) Alison B. Kohan Current Opinion in Endocrinology Diabetes and Obesity
- The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
- (2015) Hussein N. Yassine et al. PLoS One
- Rare Variant APOC3 R19X Is Associated With Cardio-Protective Profiles in a Diverse Population-Based Survey as Part of the Epidemiologic Architecture for Genes Linked to Environment Study
- (2014) D. C. Crawford et al. Circulation-Cardiovascular Genetics
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families
- (2013) A.E. Bochem et al. CLINICAL GENETICS
- Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets
- (2013) Mikael Larsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates
- (2013) Ioanna Tachmazidou et al. Nature Communications
- Implementing a successful data-management framework: the UK10K managed access model
- (2013) Dawn Muddyman et al. Genome Medicine
- Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
- (2012) G. Reyes-Soffer et al. DIABETES CARE
- Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
- (2012) N Faghihnia et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- 32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT
- (2011) M.J. Chapman et al. ATHEROSCLEROSIS SUPPLEMENTS
- Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia
- (2011) Kevin C. Maki et al. Journal of Clinical Lipidology
- Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
- (2011) Esther M. M. Ooi et al. JOURNAL OF LIPID RESEARCH
- Silencing disease genes in the laboratory and the clinic
- (2011) Jonathan K Watts et al. JOURNAL OF PATHOLOGY
- Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
- (2010) Sandrine Caron et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
- (2010) Carlos Hernandez et al. Cell Metabolism
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
- (2010) Chunyu Zheng et al. CIRCULATION
- ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
- (2009) A. Hiukka et al. DIABETES
- Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans
- (2008) Mirjana Pavlic et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Atorvastatin and Fenofibrate Have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men With the Metabolic Syndrome
- (2008) Dick C. Chan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- Fatty liver, insulin resistance, and dyslipidemia
- (2008) Martin Adiels et al. Current Diabetes Reports
- Dose-Dependent Effect of Rosuvastatin on VLDL-Apolipoprotein C-III Kinetics in the Metabolic Syndrome
- (2008) E. M.M. Ooi et al. DIABETES CARE
- Structure and Dynamics of Human Apolipoprotein CIII
- (2008) Chinthaka Saneth Gangabadage et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular processes that handle — and mishandle — dietary lipids
- (2008) Kevin Jon Williams JOURNAL OF CLINICAL INVESTIGATION
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
- Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
- (2007) Herbert Schuster et al. ATHEROSCLEROSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search